Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Radiology
|
December 9, 2025
<sup>61</sup>Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of <sup>61</sup>Cu-labeled PET Radiotracers
Gary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
The Oncologist
|
April 8, 2015
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience
Richard M Bambury, David J Benjamin, Joshua L Chaim, et al.
JTO Clinical and Research Reports
|
November 25, 2022
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study
David J Benjamin, Shuai Chen, Joanna B Eldredge, et al.
Infectious Agents and Cancer
|
May 2, 2026
Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV)
Morgann Madill, Udhayvir Grewal, Harris Krause, et al.
The Oncologist
|
October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
Enrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
The Oncologist
|
June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens
Jeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Radiology
|
December 9, 2025
<sup>61</sup>Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of <sup>61</sup>Cu-labeled PET Radiotracers
Gary A Ulaner, Jeffrey C Bassett, Ryan Reddy, et al.
The Oncologist
|
April 8, 2015
The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience
Richard M Bambury, David J Benjamin, Joshua L Chaim, et al.
JTO Clinical and Research Reports
|
November 25, 2022
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study
David J Benjamin, Shuai Chen, Joanna B Eldredge, et al.
Infectious Agents and Cancer
|
May 2, 2026
Genomic and transcriptomic differences between neuroendocrine neoplasms and carcinomas with human papillomavirus (HPV)
Morgann Madill, Udhayvir Grewal, Harris Krause, et al.
The Oncologist
|
October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
Enrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
The Oncologist
|
June 19, 2025
REFINE: a database of linked clinical data and genomic biomarkers in renal cell carcinoma patients receiving immunotherapy-based treatment regimens
Jeffrey Zhong, Albert Jang, Bashar Abuqayas, et al.
Page
of 9